Рейтинг компаний по расходам на R&D

Short Name R&D расходы, $
1 ROCHE HLDG-GENUS 10,919,999,078
2 NOVARTIS AG-REG 9,086,000,128
3 JOHNSON&JOHNSON 8,494,000,128
4 PFIZER INC 8,392,999,936
5 MERCK & CO 7,180,000,256
6 SANOFI 6,408,626,712
7 GLAXOSMITHKLINE 5,683,438,585
8 ASTRAZENECA PLC 5,578,999,808
9 ELI LILLY & CO 4,733,599,744
10 BRISTOL-MYER SQB 4,534,000,128
11 AMGEN INC 4,296,999,936
12 TAKEDA PHARMACEU 3,493,223,986
13 ABBVIE INC 3,296,999,936
14 GILEAD SCIENCES 2,854,000,128
15 OTSUKA HOLDINGS 2,486,434,278
16 NOVO NORDISK-B 2,452,338,082
17 CELGENE CORP 2,430,599,936
18 MERCK KGAA 2,263,345,175
19 BIOGEN INC 1,893,421,952
20 ASTELLAS PHARMA 1,888,772,663
21 DAIICHI SANKYO 1,743,101,324
22 REGENERON PHARM 1,271,352,960

Источник: Bloomberg

Рейтинги